Literature DB >> 2107503

Characterization of major surface and excretory-secretory immunogens of Trypanosoma cruzi trypomastigotes and identification of potential protective antigen.

M A Ouaissi1, A Taibi, J Cornette, P Velge, B Marty, M Loyens, M Esteva, F S Rizvi, A Capron.   

Abstract

The surface antigens of Trypanosoma cruzi trypomastigotes were identified by immunoprecipitation and were compared with metabolically labelled excretory-secretory products (ES) released by the parasites in vitro. A series of major immunogenic components in the ES antigens were revealed (160 kDa, 130 kDa and 80-110 kDa). The trypomastigote surface also bears the 130 kDa band and the 80-110 kDa complex. Competition experiments demonstrated the common antigenic structure of the ES and the surface antigens. Two-dimensional analysis of ES antigens immunoprecipitated by human Chagasic serum revealed several spots in the 80-110 kDa region with a wide range of isoelectric points (PI between 5.4 and 6.7). This reflects a charge heterogeneity of these polypeptides. The trypomastigote 85 kDa polypeptide was also identified in the ES antigens by using a monoclonal antibody against this antigen. Two-dimensional analysis of the 85 kDa proteins shed from the surface of trypomastigotes and immunoprecipitated by the monoclonal antibody 155D3 showed 2 major spots: a major part of the 85 kDa polypeptide was found at pH 6.5-6.6, whereas a substantial amount of the antigen was found at pH 5.7. An additional component with molecular weight of approximately 58 kDa and isoelectric points of 6.5 and 6.6, was also visualized. Detection of the 85 kDa polypeptide circulating in serum from patients with acute and chronic Chagas' disease was achieved using an enzyme-linked immunosorbent assay. In addition, the data obtained showed that a polyclonal antibody to the 85 kDa polypeptide could be used to passively induce a partial protection of Fischer rats against acute lethal infection. Thus, the antigens recognized by polyclonal antibody appear to play a role in the development of protective immunity against T. cruzi.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2107503     DOI: 10.1017/s0031182000060182

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  14 in total

1.  Vaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection.

Authors:  B Wizel; N Garg; R L Tarleton
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

2.  85-kDa protein of Trypanosoma cruzi purified by affinity chromatography used in the multiple antigen binding assay (MABA) for the diagnosis of T. cruzi infection in a Venezuelan rural community.

Authors:  Mariolga Berrizbeitia; Brian J Ward; José Bubis; Marcelo Gottschalk; Alberto Aché; Deisy Perdomo; Rafael Medina; Mehudy Medina; Lilian Spencer; Momar Ndao
Journal:  Parasitol Res       Date:  2010-02-24       Impact factor: 2.289

3.  Characterization and Diagnostic Application of Trypanosoma cruzi Trypomastigote Excreted-Secreted Antigens Shed in Extracellular Vesicles Released from Infected Mammalian Cells.

Authors:  Norma L Bautista-López; Momar Ndao; Fabio Vasquez Camargo; Takeshi Nara; Takeshi Annoura; Darryl B Hardie; Christoph H Borchers; Armando Jardim
Journal:  J Clin Microbiol       Date:  2016-12-14       Impact factor: 5.948

Review 4.  Carbohydrate immunity in American trypanosomiasis.

Authors:  L R Travassos; I C Almeida
Journal:  Springer Semin Immunopathol       Date:  1993

5.  Further characterization of protective Trypanosoma cruzi-specific CD4+ T-cell clones: T helper type 1-like phenotype and reactivity with shed trypomastigote antigens.

Authors:  S P Nickell; M Keane; M So
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

6.  Shift of excretory-secretory immunogens of Trypanosoma cruzi during human Chagas' disease.

Authors:  E E Jazín; A O Luquetti; A Rassi; A C Frasch
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

7.  Ecto-ATPase activity on the surface of Trypanosoma cruzi and its possible role in the parasite-host cell interaction.

Authors:  Danielle F R Bisaggio; Carlos Eduardo Peres-Sampaio; José Roberto Meyer-Fernandes; Thaïs Souto-Padrón
Journal:  Parasitol Res       Date:  2003-08-22       Impact factor: 2.289

Review 8.  Chagas' disease.

Authors:  H B Tanowitz; L V Kirchhoff; D Simon; S A Morris; L M Weiss; M Wittner
Journal:  Clin Microbiol Rev       Date:  1992-10       Impact factor: 26.132

9.  Polyclonal cell activity of a repeat peptide derived from the sequence of an 85-kilodalton surface protein of Trypanosoma cruzi trypomastigotes.

Authors:  J Pestel; J P Defoort; H Gras-Masse; D Afchain; A Capron; A Tartar; A Ouaissi
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

10.  A 24,000 MW Trypanosoma cruzi antigen is a B-cell activator.

Authors:  A C Da Silva; A G Espinoza; A Taibi; A Ouaissi; P Minoprio
Journal:  Immunology       Date:  1998-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.